Asterias Biotherapeutics Inc
(AST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | |
| Assets | |
| Current Assets | |
| TOTAL | $4 |
| Non-Current Assets | |
| TOTAL | $N/A |
| Total Assets | $4 |
| Liabilities | |
| Current Liabilities | |
| Other current liabilities | 761 |
| TOTAL | $761 |
| Non-Current Liabilities | |
| TOTAL | $N/A |
| Total Liabilities | $761 |
| Shareholders' Equity | |
| Retained earnings | -759 |
| Other shareholders' equity | -50 |
| TOTAL | $-757 |
| Total Liabilities And Equity | $4 |